Antimicrobial Stewardship: Selected Reads

This study evaluated the association between mortality and delays in reporting blood culture positivity and bacterial species identification in 6,225 patients with bacteremia treated at a Barcelona hospital from January 2013 to December 2019.

This study evaluated the use of antigen assays to screen for Histoplasma capsulatum and Cryptococcus neoformans in 280 people living with HIV who had CD4+ counts of less than 350 cells per cubic millimeter (mm3) from November 2021 to June 2022 at an HIV clinic in Trinidad.

This retrospective study evaluates the incidence of invasive fungal infections (IFIs) in 308 children who received an allogenic hematopoietic stem cell transplant in a French hospital that relies on environmental hygiene and air filtration, rather than systematic primary antifungal prophylaxis, from 2010 to 2020.

This article summaries discussions involving academia, the pharmaceutical industry, patient groups, and government agencies held during a 2020 US Food and Drug Administration (FDA) workshop to improve the regulatory and clinical trial infrastructure necessary to develop antifungals for invasive fungal infections.

This review examines the intersecting patient characteristics, clinical and imaging signs and pathways, and diagnostic tests available and in development to aid in rapid assessment of invasive fungal respiratory infections in immunocompromised people.

This review highlights current insights into the emergence and spread of antimicrobial resistance (AMR) from a One Health perspective. A major challenge for One Health studies is attributing the directionality of transmission of antimicrobial resistance genes (ARGs) between different metagenomes.